top of page
AOD 9604 is a peptide.jpg

AOD-9604

Clinically Shown to Reduce Abdominal Fat

Potential Benefits of AOD-9604

Targeted Fat-Metabolism Support

A synthetic fragment of human growth hormone (hGH 177-191) studied for its role in lipolysis and adipose-tissue metabolism.

Program-Friendly

Often incorporated alongside nutrition, sleep, and training plans as part of a comprehensive body-composition program.

Convenient Administration

Clinic protocols typically use small subcutaneous injections with flexible scheduling.

Important: AOD-9604 is not FDA-approved for any indication and availability varies by jurisdiction. Evidence in humans is limited and mixed. Use only under the guidance of a licensed clinician.

Contraindications & Precautions

Contraindications

  • Known hypersensitivity to AOD-9604 or formulation components

  • Pregnancy or breastfeeding

  • Active malignancy (or history of cancer without verified remission)

Use with Caution

  • Diabetes or impaired glucose tolerance — monitor glucose/A1c as directed

  • Significant cardiovascular, hepatic, or renal disease — specialist oversight

  • Concurrent use with other weight-management drugs or GH-axis therapies

  • Allergy history; prior injection-site reactions

Outcomes, Dosing & Side Effects

Reported/Program Outcomes

  • Support for fat-loss programs when paired with diet and activity

  • Some clients report reduced cravings or improved adherence

  • Expectations should be conservative; individual responses vary

Dosing & Administration

  • Route: Subcutaneous injection

  • Frequency: Clinic protocols vary (commonly daily; 5–7 days/week)

  • Timing: Morning or evening per prescriber/program

  • Sites: Abdomen, thigh, or upper arm — rotate sites

Exact dose and schedule are individualized and determined by your licensed provider. Follow clinic instructions and monitoring plans.

Side Effects — Common

  • Injection-site redness, itching, or bruising

  • Headache, nausea, indigestion

  • Dizziness, flushing, mild fatigue

  • Sleep changes or vivid dreams (occasionally reported)

Side Effects — Serious/Rare

  • Allergic reactions (rash, swelling, breathing difficulty) — seek care

  • Marked or persistent palpitations, chest pain, or severe dizziness — evaluate promptly

  • Worsening glucose control — contact your provider

Why Choose AOD-9604?

AOD-9604 is a laboratory-made peptide corresponding to the C-terminal region of hGH (amino acids 177–191). It has been explored for its potential to influence fat-metabolism pathways while avoiding traditional GH replacement.

Patient Story:
“With structured nutrition and routine exercise, I noticed steadier progress around my midsection over two months. The simple injections were easy to fit into my week.” — Keisha W.

Proposed Mechanism

  • hGH-Fragment Activity: Peptide derived from the lipolytic region of growth hormone (177–191)

  • Lipolysis/Lipogenesis Balance: Preclinical and early human work suggests effects on fat breakdown and storage pathways

  • No GH Replacement: Does not function as growth hormone; programs do not substitute for GH therapy

  • Administration: Subcutaneous micro-dose protocols under clinician supervision

bottom of page